Skip to main content
logo
Genertec Universal Medical Group Company Limited (HKG:2666)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.705
-0.030 (-0.63%)
Sep 9, 2026, 3:35 PM HKT

HKG:2666 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,2342,2092,1042,1101,9601,948
Depreciation & Amortization
853.56788.46602.26508.67442.05319.46
Loss (Gain) From Sale of Investments
38.4838.48-300.26-289.32-140.89256.75
Asset Writedown & Restructuring Costs
---0.04--
Provision for Credit Losses
330.86330.86322.92192.1307.14318.24
Loss (Gain) on Equity Investments
9.099.09-26.56-6.38-13.46-13.87
Stock-Based Compensation
---1.060.445.8
Change in Accounts Payable
73.8473.84-776.19557.17639.63171.1
Change in Trading Asset Securities
-8.92-8.9210.63-11.08--
Change in Other Net Operating Assets
1,2321,232-3,107-996.39-3,712-6,076
Other Operating Activities
-760.461,5262,2762,8902,6001,717
Operating Cash Flow
3,5805,7761,1384,9942,032-1,401
Operating Cash Flow Growth
-35.95%407.45%-77.21%145.76%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,034-988.91-1,255-896.83-617.87-385.07
Sale of Property, Plant & Equipment
13.7612.4212.040.070.270.15
Cash Acquisitions
-0.35-239.15-409.55436.7347.47
Divestitures
-0.86-0.86-0.04---
Investment in Securities
-113.1-35.7373.0481.41168.93-274.6
Other Investing Activities
41.7353.98324.21165.91-109.46-52.48
Investing Cash Flow
-1,092-958.75-1,085-1,059-121.4-664.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-38,77544,93547,37333,47635,610
Long-Term Debt Repaid
--41,799-43,055-47,032-32,663-31,590
Lease Payments
-658.99-676.15-178.12-716.8-1,128-314.96
Net Debt Issued (Repaid)
-1,235-3,0241,880341.19812.644,020
Issuance of Common Stock
-----969.41
Common Dividends Paid
-11.36-615.5-604.47-591.98-580.46-482.98
Other Financing Activities
-954.53-1,455-1,796-3,543-1,809-2,115
Financing Cash Flow
-2,201-5,094-520.67-3,794-1,5762,392

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-47.515.35-2.342.3-25.25-21.14
Net Cash Flow
238.6-271.52-469.67143.63309305.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,5464,787-116.764,0971,414-1,786
Free Cash Flow Growth
-44.56%--189.71%--
Free Cash Flow Margin
18.13%32.93%-0.88%30.53%12.06%-18.67%
Free Cash Flow Per Share
1.262.38-0.061.970.68-0.88
Free Cash Flow After Leases
1,8874,111-294.883,380286.33-2,101

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,4221,6301,9452,3151,9801,686
Cash Income Tax Paid
718.64793.25735.76727.33705.78709.69